Literature DB >> 16174796

Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation.

Anthony Lemarie1, Claudie Morzadec, Delphine Mérino, Olivier Micheau, Olivier Fardel, Laurent Vernhet.   

Abstract

Arsenic trioxide (As(2)O(3)) is known to be toxic toward leukemia cells. In this study, we determined its effects on survival of human monocytic cells during macrophagic differentiation, an important biological process involved in the immune response. As(2)O(3) used at clinically relevant pharmacological concentrations induced marked apoptosis of human blood monocytes during differentiation with either granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. Apoptosis of monocytes was associated with increased caspase activities and decreased DNA binding of p65 nuclear factor-kappaB (NF-kappaB); like As(2)O(3), the selective NF-kappaB inhibitor (E)-3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (Bay 11-7082) strongly reduced survival of differentiating monocytes. The role of NF-kappaB in arsenic toxicity was also studied in promonocytic U937 cells during phorbol 12-myristate 13-acetate-induced macrophagic differentiation. In these cells, As(2)O(3) first reduced DNA binding of p65 NF-kappaB and subsequently induced apoptosis. In addition, overexpression of the p65 NF-kappaB subunit, following stable infection with a p65 retroviral expressing vector, increased survival of As(2)O(3)-treated U937 cells. As(2)O(3) specifically decreased protein levels of X-linked inhibitor of apoptosis protein and FLICE-inhibitory protein, two NF-kappaB-regulated genes in both U937 cells and blood monocytes during their differentiations. Finally, As(2)O(3) was found to inhibit macrophagic differentiation of monocytic cells when used at cytotoxic concentrations; however, overexpression of the p65 NF-kappaB subunit in U937 cells reduced its effects toward differentiation. In contrast to monocytes, well differentiated macrophages were resistant to low concentrations of As(2)O(3). Altogether, our study demonstrates that clinically relevant concentrations of As(2)O(3) induced marked apoptosis of monocytic cells during in vitro macrophagic differentiation likely through inhibition of NF-kappaB-related survival pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174796     DOI: 10.1124/jpet.105.092874

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

Review 1.  Double-Sided Personality: Effects of Arsenic Trioxide on Inflammation.

Authors:  Juan Zhang; Yue Zhang; Weiyan Wang; Chunling Li; Zhiyi Zhang
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

2.  Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood.

Authors:  Molly L Kile; E Andres Houseman; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Andres Cardenas; Robert O Wright; David C Christiani
Journal:  Epigenetics       Date:  2014-02-13       Impact factor: 4.528

Review 3.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

4.  Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury.

Authors:  Shengbo Han; Hui Wu; Wenxue Li; Pan Gao
Journal:  Mol Cell Biochem       Date:  2015-01-28       Impact factor: 3.396

5.  Toxoplasma gondii infection inhibits the mitochondrial apoptosis through induction of Bcl-2 and HSP70.

Authors:  Il-Young Hwang; Juan Hua Quan; Myoung-Hee Ahn; Hassan Ahmed Hassan Ahmed; Guang-Ho Cha; Dae-Whan Shin; Young-Ha Lee
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

6.  Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors.

Authors:  Priyanka Prasad; Dona Sinha
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

Review 7.  Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex.

Authors:  Daniele Ferrario; Laura Gribaldo; Thomas Hartung
Journal:  Curr Environ Health Rep       Date:  2016-03

8.  Unfolded protein response (UPR) signaling regulates arsenic trioxide-mediated macrophage innate immune function disruption.

Authors:  Ritesh K Srivastava; Changzhao Li; Sandeep C Chaudhary; Mary E Ballestas; Craig A Elmets; David J Robbins; Sadis Matalon; Jessy S Deshane; Farrukh Afaq; David R Bickers; Mohammad Athar
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-14       Impact factor: 4.219

9.  Chronic arsenic exposure impairs macrophage functions in the exposed individuals.

Authors:  Nilanjana Banerjee; Saptarshi Banerjee; Rupashree Sen; Apurba Bandyopadhyay; Nilendu Sarma; Papiya Majumder; Jayanta K Das; Mitali Chatterjee; Syed N Kabir; Ashok K Giri
Journal:  J Clin Immunol       Date:  2009-06-10       Impact factor: 8.317

10.  Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65.

Authors:  Shihui Li; Fang Xue; Zhiyong Cheng; Xiaoyang Yang; Suyun Wang; Fengyong Geng; Ling Pan
Journal:  Int J Hematol       Date:  2009-08-29       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.